Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Bio-Rad Laboratories, Inc. on April 26, 2011. The filing details the outcomes of five specific matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance data.
Material Changes and Voting Results
The following matters were voted upon and approved by stockholders:
- Election of Directors: All six nominees were elected. Class A directors (Louis Drapeau, Albert J. Hillman) received over 16 million votes each. Class B directors (Dr. Ted W. Love, Alice N. Schwartz, David Schwartz, Norman Schwartz) received over 4.8 million votes each.
- Auditor Ratification: Stockholders ratified the selection of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2011, with 7,151,437 votes for and 1,495 against.
- Employee Stock Purchase Plan: The 2011 Employee Stock Purchase Plan was approved with 6,731,675 votes for and 48,155 against.
- Executive Compensation (Say-on-Pay): The advisory vote on executive compensation was approved with 6,716,867 votes for and 77,542 against.
- Frequency of Compensation Votes: Stockholders voted to hold the advisory vote on executive compensation every 3 years (5,690,841 votes for 3 years vs. 1,042,159 for 1 year).
Guidance, Outlook, and Management Commentary
Based on the voting results regarding the frequency of executive compensation votes, management stated that the Company will include the advisory vote on executive compensation in its proxy materials every 3 years until the next required vote on the frequency of such advisory votes. No other guidance, outlook, or risk factors were disclosed in this filing.
Investor Verification Checklist
- Verify the composition of the Board of Directors following the election of the six nominees.
- Confirm the implementation of the 2011 Employee Stock Purchase Plan.
- Note the established 3-year cycle for future executive compensation advisory votes.
- Review the full proxy statement for detailed biographical information on the elected directors and specific terms of the stock purchase plan.